Alpha 2B or 2B/2C adrenoceptor agonists for the treatment of neurodegeneration

Details for Australian Patent Application No. 2011239265 (hide)

Owner Allergan, Inc.

Inventors Gil, Daniel W.; Wheeler, Larry A.; Donello, John E.

Agent Davies Collison Cave

Pub. Number AU-A-2011239265

Parent 2009238370

Filing date 21 October 2011

Wipo publication date 10 November 2011

International Classifications

A61K 31/17 (2006.01) - having the group NC(O)N or NC(S)N, e.g. urea, thiourea, carmustine

A61K 31/00 (2006.01)

A61K 31/4174 (2006.01)

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

10 November 2011 Application Open to Public Inspection

  Published as AU-A-2011239265

10 November 2011 Complete Application Filed

9 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under Reg. 22.2B(2). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011239266-Anti-microRNA oligonucleotide molecules

2011239264-Carbon dioxide recovery method and carbon-dioxide-recovery-type steam power generation system